Correction: Identification of potential prognostic biomarkers of thymoma with myasthenia gravis based on serum proteomics

Saved in:
Bibliographic Details
Main Authors: Xiaoting Lin, Peng Liu, Guoyan Qi
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-07-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2025.1650718/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850095021872644096
author Xiaoting Lin
Xiaoting Lin
Xiaoting Lin
Xiaoting Lin
Peng Liu
Peng Liu
Peng Liu
Peng Liu
Guoyan Qi
Guoyan Qi
Guoyan Qi
Guoyan Qi
author_facet Xiaoting Lin
Xiaoting Lin
Xiaoting Lin
Xiaoting Lin
Peng Liu
Peng Liu
Peng Liu
Peng Liu
Guoyan Qi
Guoyan Qi
Guoyan Qi
Guoyan Qi
author_sort Xiaoting Lin
collection DOAJ
format Article
id doaj-art-b75c3b90e5684be99bafa433dc7e5f62
institution DOAJ
issn 1664-3224
language English
publishDate 2025-07-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj-art-b75c3b90e5684be99bafa433dc7e5f622025-08-20T02:41:32ZengFrontiers Media S.A.Frontiers in Immunology1664-32242025-07-011610.3389/fimmu.2025.16507181650718Correction: Identification of potential prognostic biomarkers of thymoma with myasthenia gravis based on serum proteomicsXiaoting Lin0Xiaoting Lin1Xiaoting Lin2Xiaoting Lin3Peng Liu4Peng Liu5Peng Liu6Peng Liu7Guoyan Qi8Guoyan Qi9Guoyan Qi10Guoyan Qi11Department of Oncology, Hebei Medical University, Shijiazhuang, Hebei, ChinaTreatment Center of Myasthenia Gravis, People’s Hospital of Shijiazhuang, Shijiazhuang, Hebei, ChinaHebei Provincial Key Laboratory of Myasthenia Gravis, Shijiazhuang, Hebei, ChinaHebei Provincial Clinical Research Center for Myasthenia Gravis, Shijiazhuang, Hebei, ChinaDepartment of Oncology, Hebei Medical University, Shijiazhuang, Hebei, ChinaTreatment Center of Myasthenia Gravis, People’s Hospital of Shijiazhuang, Shijiazhuang, Hebei, ChinaHebei Provincial Key Laboratory of Myasthenia Gravis, Shijiazhuang, Hebei, ChinaHebei Provincial Clinical Research Center for Myasthenia Gravis, Shijiazhuang, Hebei, ChinaDepartment of Oncology, Hebei Medical University, Shijiazhuang, Hebei, ChinaTreatment Center of Myasthenia Gravis, People’s Hospital of Shijiazhuang, Shijiazhuang, Hebei, ChinaHebei Provincial Key Laboratory of Myasthenia Gravis, Shijiazhuang, Hebei, ChinaHebei Provincial Clinical Research Center for Myasthenia Gravis, Shijiazhuang, Hebei, Chinahttps://www.frontiersin.org/articles/10.3389/fimmu.2025.1650718/fullthymomamyasthenia gravisproteomicsprognosticbiomarkers
spellingShingle Xiaoting Lin
Xiaoting Lin
Xiaoting Lin
Xiaoting Lin
Peng Liu
Peng Liu
Peng Liu
Peng Liu
Guoyan Qi
Guoyan Qi
Guoyan Qi
Guoyan Qi
Correction: Identification of potential prognostic biomarkers of thymoma with myasthenia gravis based on serum proteomics
Frontiers in Immunology
thymoma
myasthenia gravis
proteomics
prognostic
biomarkers
title Correction: Identification of potential prognostic biomarkers of thymoma with myasthenia gravis based on serum proteomics
title_full Correction: Identification of potential prognostic biomarkers of thymoma with myasthenia gravis based on serum proteomics
title_fullStr Correction: Identification of potential prognostic biomarkers of thymoma with myasthenia gravis based on serum proteomics
title_full_unstemmed Correction: Identification of potential prognostic biomarkers of thymoma with myasthenia gravis based on serum proteomics
title_short Correction: Identification of potential prognostic biomarkers of thymoma with myasthenia gravis based on serum proteomics
title_sort correction identification of potential prognostic biomarkers of thymoma with myasthenia gravis based on serum proteomics
topic thymoma
myasthenia gravis
proteomics
prognostic
biomarkers
url https://www.frontiersin.org/articles/10.3389/fimmu.2025.1650718/full
work_keys_str_mv AT xiaotinglin correctionidentificationofpotentialprognosticbiomarkersofthymomawithmyastheniagravisbasedonserumproteomics
AT xiaotinglin correctionidentificationofpotentialprognosticbiomarkersofthymomawithmyastheniagravisbasedonserumproteomics
AT xiaotinglin correctionidentificationofpotentialprognosticbiomarkersofthymomawithmyastheniagravisbasedonserumproteomics
AT xiaotinglin correctionidentificationofpotentialprognosticbiomarkersofthymomawithmyastheniagravisbasedonserumproteomics
AT pengliu correctionidentificationofpotentialprognosticbiomarkersofthymomawithmyastheniagravisbasedonserumproteomics
AT pengliu correctionidentificationofpotentialprognosticbiomarkersofthymomawithmyastheniagravisbasedonserumproteomics
AT pengliu correctionidentificationofpotentialprognosticbiomarkersofthymomawithmyastheniagravisbasedonserumproteomics
AT pengliu correctionidentificationofpotentialprognosticbiomarkersofthymomawithmyastheniagravisbasedonserumproteomics
AT guoyanqi correctionidentificationofpotentialprognosticbiomarkersofthymomawithmyastheniagravisbasedonserumproteomics
AT guoyanqi correctionidentificationofpotentialprognosticbiomarkersofthymomawithmyastheniagravisbasedonserumproteomics
AT guoyanqi correctionidentificationofpotentialprognosticbiomarkersofthymomawithmyastheniagravisbasedonserumproteomics
AT guoyanqi correctionidentificationofpotentialprognosticbiomarkersofthymomawithmyastheniagravisbasedonserumproteomics